Published by Josh White on 15th November 2022
(Sharecast News) - Biotechnology developer Destiny Pharma announced the start of an investigational new drug (IND)-enabling safety study with its novel 'XF-73 Dermal' formulation.
URL: http://www.digitallook.com/dl/news/story/33109886/...